TransAct CEO exercises 8,675 RSUs into common stock
TransAct Technologies CEO John Dillon exercised previously granted Restricted Stock Units that vested under the company’s 2014 Equity Incentive Plan, converting 8,675 RSUs into the same number of common shares at a price of $0.00 per share.
Rhea-AI Filing Summary
TransAct Technologies CEO John Dillon exercised previously granted Restricted Stock Units that vested under the company’s 2014 Equity Incentive Plan, converting 8,675 RSUs into the same number of common shares at a price of $0.00 per share.
After these derivative exercises and conversions on February 28, March 1, and March 2, Dillon directly owned 167,218 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,675 shares exercised/converted
Exercise
6 txns
Insider
DILLON JOHN
Role
CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,250 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,250 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,600 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,600 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 5,825 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,825 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 13,250 contracts (Direct);
Common Stock — 167,218 shares (Direct)
Footnotes (3)
- F1. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
- F2. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
- F3. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TACT CEO John Dillon report in this Form 4 filing?
John Dillon reported the exercise and conversion of vested Restricted Stock Units into common stock. These transactions reflect equity awards under TransAct’s 2014 Equity Incentive Plan, increasing his directly owned common shares without any open-market purchases or sales.
On what dates did the TACT RSU conversions take place?
The RSU conversions occurred on February 28, March 1, and March 2, 2026. Each date involved exercises of vested Restricted Stock Units that had been granted in prior years under the 2014 Equity Incentive Plan and were converting into common stock.
What is John Dillon’s direct common stock ownership after these transactions?
After these transactions, John Dillon directly owned 167,218 shares of TransAct common stock. This figure reflects his holdings following the final RSU-to-common-stock conversion reported, showing his updated direct equity stake in the company.
Were the TACT CEO’s transactions open-market buys or sales?
The transactions were not open-market buys or sales; they were derivative exercises and conversions. Dillon’s Restricted Stock Units vested and converted into common stock at a stated price of $0.00 per share, consistent with typical equity award settlement mechanics.
Which equity plan governed the Restricted Stock Units exercised by TACT’s CEO?
The Restricted Stock Units were issued under TransAct’s 2014 Equity Incentive Plan, as Amended and Restated. Footnotes state that these RSUs vest 25% annually starting one year after grant and convert into common stock on a one-for-one basis upon vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
